MedTrace Logo

Safe Generations Plus: Swaziland PMTCT LTF Study

NCT02969161 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 616

Last updated 2018-01-24

No results posted yet for this study

Summary

This study is to understand how to improve retention in care and treatment services to HIV positive pregnant women and their babies in Swaziland. The investigators will evaluate outcomes of patients who are lost-to-follow-up (LTF) under a new approach for prevention of mother-to-child (PMTCT) called Option B+, where all HIV positive pregnant women initiate lifelong antiretroviral therapy (ART) regardless of their disease stage. The goal is to understand the outcomes of patients who are LTF from care, and the reasons for disengagement from care in the context of PMTCT in order to inform efforts to improve retention in care among patients under Option B+.

Conditions

  • HIV (Human Immunodeficiency Virus)

Sponsors & Collaborators

Principal Investigators

  • William Reidy, PhD · ICAP at Columbia University

  • Elaine Abrams, PhD · ICAP at Columbia University

  • Averie Gachuhi, MSc · ICAP at Columbia University

  • Harriet Nuwagaba-Biribonwoha, MBChB, PhD · ICAP at Columbia University

Eligibility

Min Age
1 Year
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2017-05-31
Completion
2017-09-30

Countries

  • Eswatini

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02969161 on ClinicalTrials.gov